Neurology News

New Report Outlines Current Understanding of Neurological Complications Associated With COVID-19

15 May 2020

The Environmental Neurology Specialty Group (ENSG) of the World Federation of Neurology (WFN) has published a report that details current understanding of the neurologic impacts of coronavirus disease 2019 (COVID-19). The report, published in the Journal of Neurological Sciences, describes various cases across the world of COVID-19 and the associated incidence of several different neurological complications, including headache, cerebrovascular disease, Guillain-Barré syndrome (GBS), and Miller Fisher syndrome.

Alzheimer’s gene contributes to blood-brain barrier breakdown

12 May 2020

Damage to the blood-brain barrier may contribute to the development of Alzheimer’s dementia in people carrying a high-risk gene variation.

New Evidence that Higher Caffeine and Urate Levels Are Protective Against Parkinson’s Disease

5 May 2020

Analysis of participants in the Harvard Biomarkers Study highlights the inverse association between low caffeine consumption and blood urate levels and PD, report scientists in JPD

Brain diseases at the time of the COVID-19 pandemic

5 May 2020

Prof Monica Di Luca, President, European Brain Council, highlights the importance of brain diseases during the COVID-19 pandemic

Navigating COVID-19 When You Have Parkinson’s Disease

4 May 2020

The Michael J. Fox Foundation for Parkinson’s Research announced that it is launching a limited series podcast beginning Wednesday, May 6, 2020, designed to help people with Parkinson’s disease and their care partners navigate their way through the COVID-19 pandemic.

How the future of brain wave research may be etched in silicon

29 Apr 2020

In a recent article published in Science Translational Medicine, a team of NIH BRAIN Initiative®-funded researchers showed how this chip manufacturing process may also help neuroscientists overcome similar challenges they face today in recording brain wave activity. 

New research gives further evidence that autoimmunity plays a role in Parkinson’s disease

17 Apr 2020

LJI scientists link immune cells to Parkinson’s disease onset. The research could make it possible to someday detect Parkinson’s disease before the onset of debilitating motor symptoms--and potentially intervene with therapies to slow the disease progression.

NIH BRAIN Initiative tool helps researchers watch neural activity in 3D

13 Apr 2020

Our ability to study networks within the nervous system has been limited by the tools available to observe large volumes of cells at once. An ultra-fast, 3D imaging technique called SCAPE microscopy, developed through the National Institutes of Health (NIH)’s Brain Research through Advancing Innovative Technologies (BRAIN) Initiative, allows a greater volume of tissue to be viewed in a way that is much less damaging to delicate networks of living cells.

Guidance management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic

2 Apr 2020

No data currently exist on how COVID-19 affects people with myasthenia gravis (MG)/LEMS or patients with other diseases on immunosuppressive therapies. However, because most patients with MG are on immunosuppressive or immunomodulatory therapies and may also have respiratory muscle weakness, there is a theoretical concern that MG/LEMS patients may be at higher risk of contracting the infection or experiencing severe manifestations of COVID-19.

Lost Smell and Taste Hint COVID-19 Can Target the Nervous System

24 Mar 2020

The symptoms suggest SARS-CoV-2 might infect neurons, raising questions about whether there could be effects on the brain that play a role in patients’ deaths, but the data are preliminary.
1